Cell Line Development: Landscape and Future Market Evolution
Cross contamination and cell line misidentification are some of the major concerns associated with the use of cell lines. It has been estimated that a net loss of USD 28 billion is incurred every year on research that cannot be replicated due to the involvement of misidentified or contaminated cell lines in the US. To carry out cell line development and characterization, factors such as source of cell lines, their development history and the biological properties of cells determine the analytical tests required for characterization. The ‘Cell Line Development Services Market, 2017-2027’ report provides an extensive study on the current market landscape and future outlook of the cell line development and characterization service platform providers. Some of the most interesting insights from our study are presented below.
The US And EU Have Emerged As Key Service Hubs
Approximately 85% of the cell line development companies are located in North America and Europe; within Asia Pacific, Australia is one of the emerging hubs
The Landscape Of Services Providers Is Steadily Evolving
Currently, over 135 organizations globally offer cell line development and characterization services
Several Start-Ups And Small Companies Have Surfaced
Several start-ups and small companies have been established to cater to the growing demand for well characterized cell lines for a variety of application areas
Stakeholders Offer A Variety of Testing Services To Meet The Growing Demand
Identity testing is currently the most popular service offering; a large proportion of the companies provide services to characterize mammalian cell lines
Non-Industry Players Have Also Demonstrated A Strong Expertise
Majority of the academic players in this field offer cell line authentication services for a variety of cell types; STR profiling is the current gold standard for identity testing
We Expect Healthy Growth in the Long Term
Given the escalating requirements for cell lines in research, bioproduction and cell therapy manufacturing, the cell line development services market is projected to grow at a healthy rate
Non-Conventional Cell Lines, Though, Are Likely To Garner Relatively Higher Interest
In the foreseen future, significant revenues are likely to come from characterization services for non-conventional cell lines and growing operations in the Asia Pacific
To learn more, please click Cell Line Services Market, 2017-2027. For any queries / suggestions, please do not hesitate to contact us at sales@rootsanalysis.com. You can also download the SAMPLE REPORT on cell line services by Roots Analysis.
Back of the Eye Disorders: Novel Drugs and Delivery Technologies
Blockchain in Genomic Data Management
T Cells: The Future Roadmap of The USD 15 Billion+ Opportunity
About Author
Arun_Gupta
Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT & technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients.